Morgan Stanley - Aug 31, 2025 SCHEDULE 13G Report for EVOKE PHARMA INC Common Stock (EVOK)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
EVOKE PHARMA INC Common Stock
Symbol
EVOK
Shares outstanding
1.56M shares
Disclosed Ownership
164K shares
Ownership
10.5%
Form type
SCHEDULE 13G
Date filed
9/8/2025, 04:33 PM
Date of event
Aug 31, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 10.5% 164K 0 0 Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Smith Barney LLC 10.5% 164K 0 0 David Galasso Authorized Signatory, Morgan Stanley Smith Barney LLC